secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2023-03-28T23:59:59+00:00
Accession:  0001628280-23-009335
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Choice FY2022 net sales $54.7M (+19% YoY) but net loss $39.3M; cash drops sharply
--------------------------------------------------------------------------------

- FY2022 net sales $54.7M (+19% YoY); Q4 net sales $9.3M (-15.6% YoY).
- Full year net loss $39.3M vs. net income $3.4M in FY2021; includes $18.6M goodwill impairment.
- Adjusted EBITDA loss widened to $(11.8)M from $(7.1)M in prior year.
- Cash and equivalents fell to $3.2M from $21.7M at year-end 2021; cash burn remains a key concern.
- International (+48%) and Brick & Mortar (+72%) drove growth; E-commerce (-3%) and DTC (-30%) declined.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023009335/0001628280-23-009335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000162828023009335/bttr-20230328.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-009335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer